日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Roles of microtubules and LIS1 in dynein transport machinery assembly

微管和LIS1在动力蛋白运输机制组装中的作用

Rao, Qinhui; Yang, Jun; Chai, Pengxin; Markus, Steven; Zhang, Kai

LIS1 mediated Schwann cell reprogramming enhances perineural invasion by activating the serine/NMDAR/AKT signaling pathway in head and neck squamous carcinoma.

LIS1 介导的雪旺细胞重编程通过激活头颈部鳞状细胞癌中的丝氨酸/NMDAR/AKT 信号通路增强神经周围侵袭。

Liu Jing, Dai Ao, Liu Yiding, Zhang Yuying, Yan Bing, Jin Dong, Wang Fu, Gao Lu

Selective Lis1 inactivation disrupts migration and positioning of cortical somatostatin interneurons.

选择性 Lis1 失活会破坏皮质生长抑素中间神经元的迁移和定位。

Pombero A, García-López R, Geijo-Barrientos E, Martínez S

Cryo-EM captures early intermediate steps in dynein activation by LIS1

冷冻电镜捕捉到LIS1激活动力蛋白的早期中间步骤

Nguyen, Kendrick H V; Karasmanis, Eva P; Kendrick, Agnieszka A; Reck-Peterson, Samara L; Leschziner, Andres E

Capturing disease severity in LIS1-lissencephaly reveals proteostasis dysregulation in patient-derived forebrain organoids.

通过捕捉 LIS1-无脑回畸形的疾病严重程度,揭示了患者来源的前脑类器官中的蛋白质稳态失调。

Zillich Lea, Gasparotto Matteo, Rossetti Andrea Carlo, Fechtner Olivia, Maillard Camille, Hoffrichter Anne, Zillich Eric, Jabali Ammar, Marsoner Fabio, Artioli Annasara, Wilkens Ruven, Schroeter Christina B, Hentschel Andreas, Witt Stephanie H, Melzer Nico, Meuth Sven G, Ruck Tobias, Koch Philipp, Roos Andreas, Bahi-Buisson Nadia, Francis Fiona, Ladewig Julia

A LisH-domain protein interaction map reveals a Lis1-ARIH2-dynein regulatory axis.

LisH结构域蛋白相互作用图揭示了Lis1-ARIH2-动力蛋白调控轴。

Molecular mechanism of dynein-dynactin complex assembly by LIS1

LIS1 组装动力蛋白-动力蛋白复合物的分子机制

Kashish Singh #, Clinton K Lau #, Giulia Manigrasso, José B Gama, Reto Gassmann, Andrew P Carter

Correction: NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90

更正:NudCL2 通过 Hsp90 稳定肌球蛋白-9 和 LIS1 来调节细胞迁移。

Chen, Wenwen; Wang, Wei; Sun, Xiaoxia; Xie, Shanshan; Xu, Xiaoyang; Liu, Min; Yang, Chunxia; Li, Min; Zhang, Wen; Liu, Wei; Wang, Liangjing; Zhou, Tianhua; Yang, Yuehong

MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1

miR-380通过沉默LIS1抑制胆管癌细胞的增殖和侵袭。

Wei, Zhicheng; Xu, Bowen; Yin, Yanjiang; Chang, Jianping; Li, Zhiyu; Zhang, Yefan; Che, Xu; Bi, Xinyu

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway

GLIS1 干预通过靶向 SGK1-STAT3-PD1 通路增强抗 PD-1 疗法治疗肝细胞癌的效果。

Rong, Dawei; Wang, Yuliang; Liu, Li; Cao, Hengsong; Huang, Tian; Liu, Hanyuan; Hao, Xiaopei; Sun, Guangshun; Sun, Guoqiang; Zheng, Zhiying; Kang, Junwei; Xia, Yongxiang; Chen, Ziyi; Tang, Weiwei; Wang, Xuehao